Novo Nordisk accused Hims of [failing] to adhere to the law which prohibits mass sales of compounded drugs under the false guise of personalization and [] disseminating deceptive marketing that put patient safety at risk. In August 2025, Novo Nordisk lowered guidance during its earnings report and partly blamed the production of compounded semaglutide for the reduction
Many people report feeling most tired during the initial weeks of treatment, particularly during the dose titration phase when the medication is being gradually increased to therapeutic levels
Moreover, GLP-1R has not yet been identified on human myocardial cells, negating any direct effects of GLP-1RAs on myocardial cells
That's a significant oversight, because the organ that may benefit most from creatine isn't the one you're training on leg day
Expression and distribution of glucagon-like peptide1 receptor mRNA, protein and binding in the male nonhuman primate (Macaca mulatta) brain
Q: Can both improve metabolic health, not just weight loss